Medical Value & Outcomes Liaison
About the role
The Medical Value and Outcomes Liaison (MVOL) is a field-based non-promotional US medical expert responsible for advancing scientific exchange and building strategic relationships with national population health decision makers (PHDMs) and within identified strategic accounts. This position will serve as a compliant medical partner supporting market access strategy through scientific exchange of the clinical and pharmacoeconomic value of PTI therapies/pipeline products to key PHDM stakeholders in community oncology, Integrated Delivery Networks (IDN), payor, Group Purchasing Organizations (GPO), and clinical pathway organizations. The role of the MVOL is non-promotional in nature and serves as a trusted scientific partner to translate health economics and outcomes research (HEOR) and real-world evidence (RWE) to key PHDM stakeholders, while extracting actionable insights to support evidence-based healthcare decisions.
Responsibilities
- Serve as a primary field medical lead to [SS1] [C(2] generate and execute scientific discussions building awareness and clinically differentiating PTI therapies within assigned strategic accounts, inclusive of national community oncology large practice networks, IDN’s, Integrated Payor Provider Networks (IPPNs), payors, and GPOs
- Develop key opinion leader (KOL) and PHDM relationships across all assigned strategic account segments
- Contribute meaningfully as a key medical stakeholder within a highly collaborative matrix environment, focusing on supporting market access and the medical HEOR team through scientific exchange in PHDM discussions reviewing the clinical and pharmacoeconomic totality of evidence for PTI therapies leveraging RWE, economic modeling, value dossiers, and budget impact models
- Identify and facilitate approval of HEOR/RWE data generation opportunities